Last reviewed · How we verify
Trigeminal neuralgia
Approved treatments
- Tegretol · Novartis AG (originally Geigy)
Carbamazepine reduces polysynaptic responses and blocks post-tetanic potentiation, potentially alleviating seizures and pain. - Carbamazepin · Enanta Pharmaceuticals, Inc
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Trigeminal neuralgia patent landscape — cliff calendar, originator estates, attackable patents
- Trigeminal neuralgia treatment landscape brief
- Trigeminal neuralgia treatment updates RSS
Frequently asked questions about Trigeminal neuralgia
What drugs treat Trigeminal neuralgia?
Tracked treatments include Tegretol, Carbamazepin.
What is the treatment for Trigeminal neuralgia?
Standard treatment for Trigeminal neuralgia includes Tegretol, Carbamazepin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Trigeminal neuralgia patent cliff · Trigeminal neuralgia CI report
- Treatment: Tegretol · Novartis AG (originally Geigy)
- Treatment: Carbamazepin · Enanta Pharmaceuticals, Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing